NCT02183155View on ClinicalTrials.gov

Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

September 30, 2000

Conditions
Healthy
Interventions
DRUG

Meloxicam - low

DRUG

Meloxicam - medium

DRUG

Meloxicam - high

DRUG

Placebo

DRUG

Extended-release indomethacin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183155 - Effect of Meloxicam Tablets on Bleeding Time in Healthy Subjects | Biotech Hunter | Biotech Hunter